Morphic Announces Participation in 2022 RBC Capital Markets Global Healthcare Conference
Get Alerts MORF Hot Sheet
Join SI Premium – FREE
WALTHAM, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that members of its management team will participate in a fireside chat at the RBC Capital Markets on Wednesday, May 18that 8:00 AM ET.
A live webcast of the event will be available on the Investor section of Morphic’s website at www.morphictx.com. An archived replay will be available on the company’s website following the conference.
About Morphic TherapeuticMorphic Therapeutic is a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer. In collaboration with AbbVie, Janssen, and Schrödinger, Morphic is advancing its pipeline and discovery activities using its proprietary MInT technology platform which leverages the Company’s unique understanding of integrin structure and biology. For more information, visit www.morphictx.com.
ContactsMorphic TherapeuticChris Erdman[email protected] 617.686.1718
Source: Morphic Therapeutic
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Xunlei Filed Its Annual Report on Form 20-F for Fiscal Year 2023
- GOODRX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against GoodRx Holdings, Inc. and Encourages Investors to Contact the Firm
- Industrial leader Dag J. Opedal elected to be the new Chair of HydrogenPro ASA
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!